Balance Sheet

Accounts Payables Accumulated Expenses Assets Cash & Current Investments Cash & Equivalents Common Equity Construction in Progress Convertible Debt Current Assets Current Deferred Revenue Current Leases Finished Goods Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Liabilities from Discontinued Operations Liabilities from Discontinued Operations Long-Term Deferred Tax Non-Current Assets Non-Current Debt Notes Payables Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Prepaid Assets Property, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw Materials Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Shares Outstanding Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares Work In Process

Cash Flow Statement

Daily Values

Growth Metrics

Others

Neuroone Medical Technologies (NMTC) Non-Current Deferred Tax Liability (2021 - 2022)

Neuroone Medical Technologies filings provide 2 years of Non-Current Deferred Tax Liability readings, the most recent being $140538.0 for Q3 2022.

On a quarterly basis, Non-Current Deferred Tax Liability rose 118.94% to $140538.0 in Q3 2022 year-over-year; TTM through Sep 2022 was $140538.0, a 118.94% increase, with the full-year FY2022 number at $140538.0, up 118.94% from a year prior.
Non-Current Deferred Tax Liability hit $140538.0 in Q3 2022 for Neuroone Medical Technologies, up from $64189.0 in the prior quarter.
In the past five years, Non-Current Deferred Tax Liability ranged from a high of $140538.0 in Q3 2022 to a low of $64189.0 in Q3 2021.